Skip to main content
Top

Learnings from Implementation Strategies to Improve Lipid Management

  • Open Access
  • 01-12-2025
  • PCSK9 Inhibitor
  • Lipid Abnormalities and Cardiovascular Prevention (NJ Pagidipati, Section Editor)
Published in:

Abstract

Purpose of Review

Lowering low-density lipoprotein (LDL)-cholesterol reduces cardiovascular risk. International lipid management guidelines recommend LDL-cholesterol goals or thresholds for initiating lipid-lowering therapy. However, contemporary real-world studies have shown that many high- and very high-risk patients are not attaining LDL-cholesterol goals and are not receiving intensive lipid-lowering therapies. In this review, recent examples of implementation strategies for optimising lipid management are discussed.

Recent Findings

Implementation studies are heterogenous in their strategies and design. At the clinician level, multidisciplinary team-based care (including multidisciplinary lipid clinics), pharmacist- or nurse-led interventions, decision-support algorithms or protocols, and educational initiatives have shown potential to improve lipid management. Various strategies to improve patient adherence to lipid-lowering therapies have demonstrated at least short-term efficacy, including education, shared decision-making, behavioural support and nudges. Electronic health records can be leveraged at low cost to identify patients requiring initiation or intensification of lipid-lowering therapies, but the optimal method of integrating automated alerts or nudges to influence decision-making requires further research. Moreover, telehealth and remote care delivery models can improve access to healthcare and facilitate lipid-lowering.

Summary

Multifaceted strategies with a systematic approach to targeting clinician, patient and system related factors can be successful in improving lipid management. Future implementation research should evaluate longer-term outcomes and follow implementation science theories, models and/or frameworks at all stages. By doing so, ongoing implementation studies will help researchers better understand the impact, sustainability and scalability of strategies, and where barriers and facilitators to lipid management may exist in other contexts.
Title
Learnings from Implementation Strategies to Improve Lipid Management
Authors
Nick S. R. Lan
Ruofei Trophy Chen
Girish Dwivedi
Gerald F. Watts
Stephen J. Nicholls
Adam J. Nelson
Publication date
01-12-2025
Publisher
Springer US
Keyword
PCSK9 Inhibitor
Published in
Current Cardiology Reports / Issue 1/2025
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-024-02174-8
This content is only visible if you are logged in and have the appropriate permissions.

Other articles of this Issue 1/2025

Left Atrial Dysfunction in Patients with Atrial Fibrillation and Heart Failure

Metabolic Regulation of Cardiovascular Aging

  • Insulins
  • Regenerative Medicine (SM Wu, Section Editor)

From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent Era

  • Open Access
  • Interventional Cardiology (SR Bailey and T Helmy, Section Editors)

The Role of Race in Pregnancy, Hypertension, and Long-Term Outcomes

  • Pre-Eclampsia
  • Diversity and Health Equity in Cardiology (AE Johnson, Section Editor)

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME